NASDAQ: ITCI - Intra-Cellular Therapies, Inc.

Rentabilidade por seis meses: +75.46%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Intra-Cellular Therapies, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc., биофармацевтическая компания, разрабатывает новые препараты для лечения психоневрологических и неврологических заболеваний и других заболеваний центральной нервной системы (ЦНС) в США. Компания разрабатывает свой ведущий кандидат на лекарство CAPLYTA для лечения шизофрении, биполярного расстройства, поведенческих нарушений, связанных с деменцией, аутизмом и другими заболеваниями ЦНС.

mais detalhes
Также разрабатывается ITI-002, который ингибирует фермент фосфодиэстеразу типа 1; ITI-214 для болезни Паркинсона; и ITI-333 для расстройств, связанных с употреблением психоактивных веществ, боли и сопутствующих психических заболеваний, включая депрессию и тревогу. Головной офис Intra-Cellular Therapies, Inc. находится в Нью-Йорке, штат Нью-Йорк.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2014-01-07
ISIN US46116X1019
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.intracellulartherapies.com
Цена ао 128.58
Alteração de preço por dia: 0% (128.58)
Alteração de preço por semana: -0.0156% (128.6)
Alteração de preço por mês: +1.08% (127.21)
Alteração de preço em 3 meses: +48.49% (86.59)
Mudança de preço em seis meses: +75.46% (73.28)
Mudança de preço por ano: +80.77% (71.13)
Mudança de preço em 3 anos: +109.38% (61.41)
Mudança de preço em 5 anos: +525.09% (20.57)
Mudança de preço em 10 anos: 0% (128.58)
Mudança de preço desde o início do ano: +52.82% (84.14)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 12.65 1
P/BV 7.5 1
P/E 0 0
EV/EBITDA -71.28 0
Total: 1.63

Eficiência

Nome Significado Nota
ROA, % -7.13 0
ROE, % -8.58 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.1455 10
Total: 7.2

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 2926.01 10
Rentabilidade Ebitda, % -49.52 0
Rentabilidade EPS, % -77.58 0
Total: 2
Mais detalhes

Data da transação Data de divulgação Insider Tipo Preço Volume Quantidade Compartilhe até, % Compartilhe depois, % Documento
23.08.2024 23.08.2024 Mates Sharon
Officer		 Comprar 74.4 2 133 790 28680 0 0.04 link
24.06.2024 25.06.2024 RIGGS RORY B
Director		 Oferta 75.57 337 193 4462 0 -0.01 link
24.06.2024 25.06.2024 RIGGS RORY B
Director		 Comprar 16.86 337 200 20000 0 0.02 link
26.02.2024 27.02.2024 Durgam Suresh K.
EVP, Chief Medical Officer		 Oferta 70.17 288 539 4112 0 -0.01 link
26.02.2024 27.02.2024 Hineline Lawrence J.
SVP of Finance, CFO		 Oferta 69.43 925 988 13337 0 -0.02 link
26.02.2024 27.02.2024 Hineline Lawrence J.
SVP of Finance, CFO		 Comprar 36.89 216 987 5882 0 0.01 link
26.02.2024 27.02.2024 Halstead Michael
EVP and General Counsel		 Oferta 69.53 549 774 7907 0 -0.01 link
11.01.2024 12.01.2024 Halstead Michael
EVP and General Counsel		 Oferta 66.83 3 341 500 50000 0 -0.06 link
11.01.2024 12.01.2024 Halstead Michael
EVP and General Counsel		 Comprar 13.6 680 000 50000 0 0.06 link
28.03.2023 30.03.2023 Neumann Mark
EVP, Chief Commercial Officer		 Oferta 54.31 847 453 15604 0 -0.02 link
13.03.2023 13.03.2023 Mates Sharon
Chairman, President & CEO		 Oferta 44.99 925 219 20565 0 -0.03 link
13.03.2023 13.03.2023 Mates Sharon
Chairman, President & CEO		 Comprar 3.26 65 200 20000 0 0.02 link
13.03.2023 13.03.2023 Hineline Lawrence J.
SVP of Finance CFO		 Oferta 44.93 250 799 5582 0 -0.01 link
13.03.2023 13.03.2023 Halstead Michael
EVP and General Counsel		 Oferta 44.94 330 039 7344 0 -0.01 link
13.03.2023 13.03.2023 Neumann Mark
EVP, Chief Commercial Officer		 Oferta 44.98 169 035 3758 0 0 link
13.03.2023 13.03.2023 Durgam Suresh K.
EVP, Chief Medical Officer		 Oferta 45.04 330 774 7344 0 -0.01 link
10.03.2023 13.03.2023 Mates Sharon
Chairman, President & CEO		 Oferta 43.15 1 802 380 41770 0 -0.05 link
10.03.2023 13.03.2023 Hineline Lawrence J.
SVP of Finance CFO		 Oferta 43.06 674 449 15663 0 -0.02 link
10.03.2023 13.03.2023 Halstead Michael
EVP and General Counsel		 Oferta 43.1 720 115 16708 0 -0.02 link
10.03.2023 13.03.2023 Neumann Mark
EVP, Chief Commercial Officer		 Oferta 43.34 370 557 8550 0 -0.01 link
21.09.2022 23.09.2022 Hineline Lawrence J.
SVP of Finance CFO		 Oferta 45.63 2 973 430 65164 0 -0.08 link
21.09.2022 23.09.2022 Hineline Lawrence J.
SVP of Finance CFO		 Comprar 15.47 1 008 090 65164 0 0.08 link
04.03.2022 04.03.2022 Durgam Suresh K.
Chief Medical Officer		 Oferta 55.52 214 307 3860 0 0 link
02.03.2022 04.03.2022 Durgam Suresh K.
Chief Medical Officer		 Oferta 56.98 238 005 4177 0 -0.01 link

Instituições Volume Compartilhar, %
FMR, LLC 11457694 11.84
Vanguard Group Inc 9094302 9.39
Blackrock Inc. 8193544 8.46
Wasatch Advisors LP 3627308 3.75
Bellevue Group AG 3066400 3.17
Avoro Capital Advisors LLC 2255555 2.33
State Street Corporation 2220850 2.29
JP Morgan Chase & Company 2072615 2.14
Geode Capital Management, LLC 2001791 2.07
Deep Track Capital, LP 2000000 2.07

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
PSYK ETF 6.54 0
AdvisorShares Psychedelics ETF 4.59804 845.99 0.20
iShares Neuroscience and Healthcare ETF 3.99412 19.72 0.03
SPDR S&P Pharmaceuticals ETF 3.60054 29.8 1.29889
First Trust NYSE Arca Biotechnology Index Fund 3.08817 16.92 0.26101
iShares U.S. Pharmaceuticals ETF 2.94832 6.09 1.97922
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 2.9373 86.72 1.2989
Virtus LifeSci Biotech Products ETF 1.63006 36.79 0.13953
Simplify Health Care ETF 0.93458 27.81 1.00373
Future Tech ETF 0.79497 426.34 0.8416
Principal Healthcare Innovators ETF 0.79497 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.78865 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.52397 51.7 0.85651
First Trust Nasdaq Pharmaceuticals ETF 0.52071 18.37 2.19901
John Hancock Multifactor Small Cap ETF 0.4976 16.88 1.54912
RiverNorth Patriot ETF 0.38022 22.15 2.28129
SoFi Next 500 ETF 0.37751 29.56 1.43041
iShares Morningstar Small-Cap Growth ETF 0.32477 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.32477 587.89 0.72598
First Trust Mid Cap Growth AlphaDEX Fund 0.30692 26.95 0.9035
First Trust Multi-Manager Small Cap Opportunities ETF 0.30233 48.51 0.31756
iShares Russell Mid-Cap Growth ETF 0.28594 29.59 0.69551
Fidelity Growth Opportunities ETF 0.24923 32.75 0.48881
First Trust Active Factor Small Cap ETF 0.24808 34.25 1.61948
ProShares UltraShort Nasdaq Biotechnology 0.21 -40.36 1.76
BNY Mellon US Mid Cap Core Equity ETF 0.20803 30.41 1.5641
Inspire Small/Mid Cap ETF 0.2052 28.65 1.92038
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.1985 21.79 1.42082
Schwab U.S. Small-Cap ETF 0.19814 17.47 1.51433
Hartford Longevity Economy ETF 0.18732 25.01 1.53371
Schwab US Mid-Cap ETF 0.17337 17.28 1.59098
iShares Morningstar Small-Cap ETF 0.16384 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.16384 30.1 1.60498
First Trust Mid Cap Core AlphaDEX Fund 0.15407 18.49 1.65423
iShares ESG Aware MSCI USA Small-Cap ETF 0.14308 18.09 1.49366
iShares Russell 2500 ETF 0.12623 18.06 1.58987
Fidelity MSCI Health Care Index ETF 0.10802 3 1.46057
Vanguard Extended Market ETF 0.1 24.2 1.34786
First Trust Multi Cap Growth AlphaDEX Fund 0.09243 41.56 1.02425
Invesco Russell 1000 Equal Weight ETF 0.07956 16.58 2.1901
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.07876 18.2 1.66828
iShares Russell Midcap ETF 0.06858 20.77 1.71565
QRAFT AI Enhanced U.S. Large Cap ETF 0.06209 31.16 1.25914
John Hancock Multifactor Mid Cap ETF 0.05694 20.65 1.52586
Hartford Multifactor US Equity ETF 0.03992 28.96 1.92094
Humankind US Stock ETF 0.03372 18.81 1.99919
Vanguard Russell 1000 Growth ETF 0.03 31.62 0.68737
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02947 17.58 1.75869
iShares Russell 1000 Growth ETF 0.02923 31.85 0.68889
SPDR Portfolio MSCI Global Stock Market ETF 0.02433 17.99 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.02246 21.94 1.69572
Vanguard ESG U.S. Stock ETF 0.02 23.54 1.26927
iShares Russell 3000 ETF 0.0147 24.83 1.43482
iShares Dow Jones U.S. ETF 0.01441 25.05 1.41797
Schwab 1000 Index ETF 0.01424 25.15 1.42441
Schwab U.S. Broad Market ETF 0.01362 24.86 1.43354
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.01318 33 1.42661
Vanguard Russell 1000 ETF 0.01 25.16 1.43539
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Avantis U.S. Equity ETF 0.00854 23.04 1.59151
Dimensional U.S. Equity ETF 0.00358 31.53 1.3557
Dimensional US Core Equity Market ETF 0.00356 30.98 1.40618
Dimensional U.S. Core Equity 2 ETF 0.00173 30.76 1.47098



Supervisor Cargo Pagamento Ano de nascimento
Mr. Michael I. Halstead J.D. President 983.65k 1973 (52 ano)
Dr. Suresh K. Durgam M.D. Executive VP & Chief Medical Officer 961.84k 1969 (56 anos)
Mr. Mark Neumann EVP & Chief Commercial Officer 998.36k 1963 (62 ano)
Mr. Juan Fernando Sanchez Vice President of Corporate Communications & Investor Relations 296.75k 1971 (54 ano)
Ms. Karen Patruno Sheehy Esq. Senior VP & Chief Compliance Officer N/A 1962 (63 ano)
Dr. Michael Olchaskey Senior VP & Head of Regulatory Affairs N/A
Mr. John A. Bardi Senior VP of Market Access, Policy & Government Affairs N/A
Dr. Robert E. Davis Ph.D. Senior VP & Chief Scientific Officer 646.12k 1951 (74 ano)
Dr. Sharon Mates Ph.D. Co-Founder, Chairman & CEO 2.23M 1953 (72 ano)
John P. Condon Senior Vice President, General Counsel & Secretary

Endereço: United States, New York, NY , 430 East 29th Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.intracellulartherapies.com